Skip to main content

Advertisement

Table 2 Anti-malarial treatment prescribed

From: Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

Drug group/treatment N %
1 st line therapy (ART-AQ) 1,217 43.0
Combination therapy – other ACT 418 14.8
DHA+AQ 240 8.5
Artemether+AQ 77 2.7
Artemether+lumefantrine 58 2.1
DHA+pyrimethamine-sulphametopirazine 13 0.5
Artesunate+SP 12 0.4
DHA+SP 6 0.2
DHA+chloroquine 5 0.2
Artesunate+chloroquine 3 0.1
Artemether+pyrimethamine-sulphametopirazine 1 0.04
Artemether+quinine 1 0.04
Artesunate+ quinine 1 0.04
DHA+artemether+lumefantrine 1 0.04
Monotherapy – artemisinin based 936 33.1
DHA 577 20.4
Artesunate 293 10.4
Artemether 55 1.9
Artesunate/artemether 10 0.4
Artemether/DHA 1 0.04
Monotherapy – non-artemisinin 260 9.2
Amodiaquine 133 4.7
SP 78 2.8
Pyrimethamine-sulphametopirazine 32 1.1
Chloroquine 14 0.5
Quinine 3 0.1
Total 2,831  
  1. DHA = dihydroartemisinine; AQ = amodiaquine; SP = sulphadoxine-pyrimethamine